LNC
EW icon

Lincoln National Corp’s Edwards Lifesciences EW Stock Holding History

Lincoln National Corp’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,959
Closed -$1.33M – 344
2024
Q1 		$1.33M Sell
13,959
-106
-0.8% -$8.9K 0.02% 433
2023
Q4 		$1.07M Sell
14,065
-169
-1% -$11.8K 0.02% 442
2023
Q3 		$986K Sell
14,234
-2,702
-16% -$217K 0.02% 410
2023
Q2 		$1.6M Sell
16,936
-832
-5% -$72.3K 0.03% 306
2023
Q1 		$1.47M Sell
17,768
-12,572
-41% -$988K 0.03% 297
2022
Q4 		$2.26M Buy
30,340
+3,617
+14% +$279K 0.05% 204
2022
Q3 		$2.21M Buy
26,723
+1,112
+4% +$107K 0.05% 194
2022
Q2 		$2.44M Buy
25,611
+117
+0.5% +$12.1K 0.06% 185
2022
Q1 		$3M Sell
25,494
-447
-2% -$50.1K 0.06% 163
2021
Q4 		$3.36M Sell
25,941
-494
-2% -$57.6K 0.07% 148
2021
Q3 		$2.99M Buy
26,435
+604
+2% +$68.9K 0.07% 158
2021
Q2 		$2.67M Buy
25,831
+2,438
+10% +$230K 0.06% 175
2021
Q1 		$1.96M Sell
23,393
-2,765
-11% -$234K 0.05% 195
2020
Q4 		$2.39M Buy
26,158
+1,367
+6% +$113K 0.06% 158
2020
Q3 		$1.98M Buy
24,791
+1,741
+8% +$136K 0.06% 167
2020
Q2 		$1.59M Buy
23,050
+445
+2% +$31.6K 0.05% 180
2020
Q1 		$1.42M Buy
22,605
+2,868
+15% +$207K 0.05% 161
2019
Q4 		$1.53M Buy
19,737
+6,525
+49% +$510K 0.05% 185
2019
Q3 		$969K Buy
13,212
+453
+4% +$31.8K 0.04% 230
2019
Q2 		$786K Buy
+12,759
New +$772K 0.03% 242
2019
Q1 		– Sell
-7,587
Closed -$387K – 519
2018
Q4 		$387K Buy
7,587
+2,073
+38% +$105K 0.02% 303
2018
Q3 		$320K Buy
5,514
+168
+3% +$8.22K 0.01% 348
2018
Q2 		$259K Buy
5,346
+591
+12% +$27.6K 0.01% 397
2018
Q1 		$221K Sell
4,755
-3,669
-44% -$159K 0.01% 428
2017
Q4 		$316K Buy
+8,424
New +$309K 0.01% 483

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Lincoln National Corp's EW Position: Q2 2024 in Review

Lincoln National Corp sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 13,959 shares — an estimated $1.33M sold.

Lincoln National Corp first reported a position in EW in Q4 2017 and held it in 25 quarters. The position peaked at $3.36M in Q4 2021. 1,297 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Lincoln National Corp reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 13,959 Edwards Lifesciences shares in Q2 2024, an estimated $1.33M.
  • Lincoln National Corp first reported a position in Edwards Lifesciences in Q4 2017 and held it in 25 quarters.
  • Lincoln National Corp's Edwards Lifesciences position peaked at $3.36M in Q4 2021.
  • 1,297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.